Furiex Pharmaceuticals, Inc. (FURX) Reports Q4 Loss of $0.68

Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) reported Q4 EPS of ($0.68), versus ($1.18) reported last year. Revenue for the quarter came in at $1.99 million, versus $283 thousand reported last year.

For earnings history and earnings-related data on Furiex Pharmaceuticals, Inc. (FURX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Adobe (ADBE) Reiterated at Hold by Stifel Amid President, CEO Change
• Lynx Equity sees Micron and SanDisk breakout as volatility normalizes